Home / Stocks / EHTH

eHealth (EHTH, Insurance Brokers) Stock Valuation & Fair Value Fairly valued

eHealth (EHTH, Insurance Brokers) trades at a blended P/E of 0.7, about 98% below its historical normal valuation, with a forward growth estimate of -33.6%. Analysts' one-year estimates have been hit 9% of the time.

No quality score is published for this company, which is normal for insurers, banks and REITs. This rating reflects valuation, forecast return and analyst accuracy only. Ratings that cite business quality require one.

Blended P/E
0.7
Normal P/E
38.2
PEG
Fwd growth
-33.6%
Div yield
0.0%
RSI (14)
28.0
Oversold
Technical context
  • Price $0.84 at the 2026-09-23 close, 14.3% below the 20-day average ($0.98) and 29.4% below the 50-day ($1.19).
  • RSI (14) at 28.0.
  • 52-week range $0.84 to $5.65: the price is 85.1% below the high and at the low.

The Street vs SeerForecast

Wall Street's mean price target for EHTH is $1.81 across 4 analysts, 115.8% above the current price. Our SeerForecast read of the same stock, formed without analyst targets: fairly valued. When the two disagree, start your digging there.

Valuation flags

Verdict history

tickerseer's rating has been fairly valued since 2026-07-31.

Blended P/E and rating by weekBlended P/E moved from 1.1 to 0.7 between 2026-07-31 and 2026-09-21, against a normal P/E of 38.2, with 0 rating changes over 18 recorded weeks.2026-07-31: P/E 1.1, Fairly valued (recalculated)2026-08-03: P/E 1.0, Fairly valued2026-08-07: P/E 1.0, Fairly valued (recalculated)2026-08-10: P/E 1.0, Fairly valued2026-08-14: P/E 1.0, Fairly valued (recalculated)2026-08-17: P/E 0.9, Fairly valued2026-08-21: P/E 0.9, Fairly valued (recalculated)2026-08-24: P/E 1.0, Fairly valued2026-08-27: P/E 1.0, Fairly valued (recalculated)2026-08-28: P/E 1.0, Fairly valued (recalculated)2026-08-30: P/E 1.0, Fairly valued (recalculated)2026-08-31: P/E 0.9, Fairly valued2026-09-05: P/E 0.9, Fairly valued (recalculated)2026-09-07: P/E 0.8, Fairly valued2026-09-12: P/E 0.8, Fairly valued (recalculated)2026-09-14: P/E 0.8, Fairly valued2026-09-19: P/E 0.8, Fairly valued (recalculated)2026-09-21: P/E 0.7, Fairly valued10.020.030.0Jul 31Aug 13Aug 26Sep 8Sep 21Normal P/E 38.2
Attractively valuedFairly valuedAbove fair valueLarger dot: a stronger reading

Not every point was recorded live. Points marked recalculated apply today's valuation rules to the metrics tickerseer archived that week.

Selected weeks: the first, the latest, and the cheapest and dearest.

WeekBlended P/EPremium to normal P/ERating
2026-07-31P/E 1.1-97%Fairly valued
2026-09-21P/E 0.7-98%Fairly valued ← now

Frequently asked questions

Is eHealth stock overvalued?

At a blended P/E of 0.7 versus its historical normal P/E of 38.2, eHealth trades about 98% below its typical valuation. tickerseer currently rates it fairly valued.

What is eHealth's fair value and PEG?

eHealth trades at a blended P/E of 0.7 against a historical normal P/E of 38.2, a forward growth estimate of -33.6%.

Has tickerseer's rating of eHealth changed?

tickerseer's rating has been fairly valued since 2026-07-31.

What is the analyst price target for eHealth?

The mean Wall Street price target for eHealth is $1.81 across 4 analysts, 115.8% above the current price. tickerseer's SeerForecast verdict is formed independently of analyst targets.

Industry: Insurance Brokers. Create a free account to see the full analysis: the SeerAI score, valuation history, and the AI research note. Options setups and metric history are part of the paid plans.

Get the free weekly earnings preview

One email each Monday with the week's named earnings setups, the reasoning, and what settled last week. Strikes and sizing stay in Premium.

It's free, and you can unsubscribe any time. We also send a short product update once a month. Educational content, not investment advice.